Show simple item record

dc.contributor.author Kacsó, Gergely
dc.contributor.author Ravasz, Dóra
dc.contributor.author Dóczi, Judit
dc.contributor.author Németh, Beáta
dc.contributor.author Madgar O,
dc.contributor.author Iordanov, Iordan
dc.contributor.author Gál, Anikó
dc.contributor.author Molnár, Mária Judit
dc.contributor.author Nagy, Zsolt
dc.contributor.author Patócs, Attila Balázs
dc.contributor.author Ádám, Veronika
dc.contributor.author Chinopoulos, Christos
dc.date.accessioned 2018-09-26T08:42:18Z
dc.date.available 2018-09-26T08:42:18Z
dc.date.issued 2016
dc.identifier 84992561377
dc.identifier.citation pagination=3463-3485; journalVolume=473; journalIssueNumber=20; journalTitle=BIOCHEMICAL JOURNAL;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/6036
dc.identifier.uri doi:10.1042/BCJ20160594
dc.description.abstract Succinate-CoA ligase is a heterodimer enzyme composed of Suclg1 -alpha- and a substrate-specific Sucla2 or Suclg2 -beta- subunit yielding ATP or GTP, respectively. In humans, the deficiency of this enzyme leads to encephalomyopathy with, or without methylmalonyl aciduria, in addition to resulting in mitochondrial DNA depletion. We generated mice lacking either one Sucla2 or Suclg2 allele. Sucla2 heterozygote mice exhibited tissue- and age-dependent decreases in Sucla2 expression associated with decreases in ATP-forming activity, but rebound increases in cardiac Suclg2 expression and GTP-forming activity. Bioenergetic parameters including substrate-level phosphorylation were not different between wild type and Sucla2 heterozygote mice unless a submaximal pharmacological inhibition of succinate-CoA ligase was concomitantly present. mtDNA contents were moderately decreased, but blood carnitine esters were significantly elevated. Suclg2 heterozygote mice exhibited decreases in Suclg2 expression but no rebound increases in Sucla2 expression or changes in bioenergetic parameters. Surprisingly, deletion of one Suclg2 allele in Sucla2 heterozygote mice still led to a rebound but protracted increase in Suclg2 expression, yielding double heterozygote mice with no alterations in GTP-forming activity or substrate-level phosphorylation, but more pronounced changes in mtDNA content and blood carnitine esters, and an increase in succinate dehydrogenase activity. We conclude that a partial reduction in Sucla2 elicits rebound increases in Suclg2 expression which is sufficiently dominant to overcome even a concomitant deletion of one Suclg2 allele, pleiotropically affecting metabolic pathways associated with succinate-CoA ligase. These results as well as the availability of the transgenic mouse colonies will be of value in understanding succinate-CoA ligase deficiency.
dc.relation.ispartof urn:issn:0264-6021
dc.title Two transgenic mouse models for beta subunit components of succinate-CoA ligase yielding pleiotropic metabolic alterations
dc.type Journal Article
dc.date.updated 2018-08-02T11:34:53Z
dc.language.rfc3066 en
dc.identifier.mtmt 3099231
dc.identifier.wos 000393756900005
dc.identifier.pubmed 27496549
dc.contributor.department SE/AOK/I/OBI/MTA-SE Neurobiokémiai Kutatócsoport
dc.contributor.department SE/AOK/I/Orvosi Biokémiai Intézet
dc.contributor.institution Semmelweis Egyetem
dc.mtmt.swordnote FELTÖLTŐ: Bökönyi Zita - bokonyi.zita@med.semmelweis-univ.hu


Files in this item

xmlui.dri2xhtml.METS-1.0.onlyFromAllowedIP

View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account